EMAIL DETAILS

Confidentiality Notice: This electronic message and any attachment(s) are confidential and may be subject to the attorney/client privilege and/or work product immunity. This e-mail is only for the use of the intended recipient(s). If you have received this e-mail in error, please notify the sender immediately by replying to this e-mail, then delete this message and any attachment(s) from your system. Any unintended transmission expressly shall not waive the attorney/client privilege or any other privilege.

---------- Forwarded message ----------
From: "261penn@gmail.com" <261penn@gmail.com>
Date: Wed, Apr 16, 2014 at 9:37 AM
Subject: RE: mutual patient
To: "Jon Glass" <jon.glass@jefferson.edu>
Cc: "Olivere Hallie" <halliebiden@gmail.com>, "Alan Hoffman" <alanlhoffman@hotmail.com>, "Yung,W K Alfred" <wyung@mdanderson.org>

> Any time starting at 7am -- earlier the better. Thx, B
> Confidentiality Notice: This electronic message and any attachment(s) are confidential and may be subject to the attorney/client privilege and/or work product immunity. This e-mail is only for the use of the intended recipient(s). If you have received this e-mail in error, please notify the sender immediately by replying to this e-mail, then delete this message and any attachment(s) from your system. Any unintended transmission expressly shall not waive the attorney/client privilege or any other privilege.
> On Wed, Apr 16, 2014 at 9:27 AM, Jon Glass <Jon.Glass@jefferson.edu>
> wrote:
>> ​We can get this started on Friday. AM is preferable. Once I hear from you I will schedule.
>> J Glass
>> ________________________________
>> From: 261penn@gmail.com <261penn@gmail.com>
>> Sent: Tuesday, April 15, 2014 7:19 PM
>> To: Jon Glass
>> Cc: Olivere Hallie; Yung,W K Alfred
>> Subject: Re: mutual patient
>> Yes
>> Confidentiality Notice: This electronic message and any attachment(s) are confidential and may be subject to the attorney/client privilege and/or work product immunity. This e-mail is only for the use of the intended recipient(s). If you have received this e-mail in error, please notify the sender immediately by replying to this e-mail, then delete this message and any attachment(s) from your system. Any unintended transmission expressly shall not waive the attorney/client privilege or any other privilege.
>> On Tue, Apr 15, 2014 at 6:06 PM, Jon Glass <Jon.Glass@jefferson.edu<mailto:Jon.Glass@jefferson.edu>> wrote:
>> I will be in touch regarding full details. Did you have labs done at md Anderson ?
>> J glass
>> On Apr 15, 2014, at 5:56 PM, "261penn@gmail.com<mailto:261penn@gmail.com>" <261penn@gmail.com<mailto:261penn@gmail.com>> wrote:
>> Friday will be great. Thanks.
>> Confidentiality Notice: This electronic message and any attachment(s) are confidential and may be subject to the attorney/client privilege and/or work product immunity. This e-mail is only for the use of the intended recipient(s). If you have received this e-mail in error, please notify the sender immediately by replying to this e-mail, then delete this message and any attachment(s) from your system. Any unintended transmission expressly shall not waive the attorney/client privilege or any other privilege.
>> On Tue, Apr 15, 2014 at 4:20 PM, Jon Glass <Jon.Glass@jefferson.edu<mailto:Jon.Glass@jefferson.edu>> wrote:
>> ​I have approval for avastin. Please let me know what day is best for you (we could probably get it done friday of this week).
>> j glass
>> ________________________________
>> From: 261penn@gmail.com<mailto:261penn@gmail.com> <261penn@gmail.com<mailto:261penn@gmail.com>>
>> Sent: Tuesday, April 15, 2014 12:14 PM
>> To: Jon Glass
>> Cc: Olivere Hallie; Hunter Biden
>> Subject: RE: mutual patient
>> Confidentiality Notice: This electronic message and any attachment(s) are confidential and may be subject to the attorney/client privilege and/or work product immunity. This e-mail is only for the use of the intended recipient(s). If you have received this e-mail in error, please notify the sender immediately by replying to this e-mail, then delete this message and any attachment(s) from your system. Any unintended transmission expressly shall not waive the attorney/client privilege or any other privilege.
>> On Tue, Apr 15, 2014 at 12:06 PM, Jon Glass <Jon.Glass@jefferson.edu<mailto:Jon.Glass@jefferson.edu>> wrote:
>> ​​I will need to get this precertified; will expedite.
>> J Glass
>> ________________________________
>> From: 261penn@gmail.com<mailto:261penn@gmail.com> <261penn@gmail.com<mailto:261penn@gmail.com>>
>> Sent: Tuesday, April 15, 2014 11:34 AM
>> To: Jon Glass
>> Cc: Olivere Hallie; Hunter Biden; Yung,W K Alfred
>> Subject: RE: mutual patient
>> Great. Anytime this week. Just let me know when.
>> Confidentiality Notice: This electronic message and any attachment(s) are confidential and may be subject to the attorney/client privilege and/or work product immunity. This e-mail is only for the use of the intended recipient(s). If you have received this e-mail in error, please notify the sender immediately by replying to this e-mail, then delete this message and any attachment(s) from your system. Any unintended transmission expressly shall not waive the attorney/client privilege or any other privilege.
>> On Tue, Apr 15, 2014 at 10:58 AM, Jon Glass <Jon.Glass@jefferson.edu<mailto:Jon.Glass@jefferson.edu>> wrote:
>> ​Certainly. I will start the process.
>> J Glass
>> ________________________________
>> From: Yung,W K Alfred <wyung@mdanderson.org<mailto:wyung@mdanderson.org>>
>> Sent: Tuesday, April 15, 2014 10:08 AM
>> To: Jon Glass
>> Cc: Downey,Ginger
>> Subject: mutual patient
>> Jon,
>> The MRI yesterday showed about the same picture as in March. The nodular enhancement is slight less, but the spectroscopy of the posterior margin showed high choline. I am impressed with the degree of dysphasia he has. I am thinking of giving him 3-4 doses of Avastin to treat the necrosis so we can have a clearer picture of the background ?tumor progression. Can you arrange for the Avastin infusion?
>> I attached a summary of his MRI pictures here, and a CD is being FedEX to you.
>> Al
>> W.K. Alfred Yung, M.D.
>> Chairman, Department of Neuro-Oncology
>> Margaret and Ben Love Chair in Clinical Cancer Care
>> UT M. D. Anderson Cancer Center, Unit 431
>> 1515 Holcombe Blvd
>> Houston, TX 77030
>> Tele: 713-794-1285
>> Fax: 713-563-0151
>> wyung@mdanderson.org
>> The information contained in this transmission contains privileged and confidential information. It is intended only for the use of the person named above. If you are not the intended recipient, you are hereby notified that any review, dissemination, distribution or duplication of this communication is strictly prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message.
>> CAUTION: Intended recipients should NOT use email communication for emergent or urgent health care matter